Radiation Induced Sarcoma after Treatment of Glioblastoma: Case Report

Authors

  • Victor Domingos Lisita Rosa Divisão de Oncologia Clínica. Hospital das Clínicas (HC) da Universidade de São Paulo (USP). Ribeirão Preto (SP), Brasil.
  • Caroline Souza dos Anjos Divisão de Oncologia Clínica. Hospital das Clínicas (HC) da Universidade de São Paulo (USP). Ribeirão Preto (SP), Brasil. https://orcid.org/0000-0003-0937-7659
  • Priscila Barile Marchi Candido Divisão de Oncologia Clínica. Hospital das Clínicas (HC) da Universidade de São Paulo (USP). Ribeirão Preto (SP), Brasil.
  • Antonio Soares Dias Junior Divisão de Oncologia Clínica. Hospital das Clínicas (HC) da Universidade de São Paulo (USP). Ribeirão Preto (SP), Brasil.
  • Evandro Airton Sordi dos Santos Divisão de Oncologia Clínica. Hospital das Clínicas (HC) da Universidade de São Paulo (USP). Ribeirão Preto (SP), Brasil.
  • Antonio Carlos Cavalcante Godoy Divisão de Oncologia Clínica. Hospital das Clínicas (HC) da Universidade de São Paulo (USP). Ribeirão Preto (SP), Brasil.
  • Fabiano P. Saggioro Divisão de Patologia do Hospital das Clínicas (HC) da Universidade de São Paulo (USP). Ribeirão Preto (SP), Brasil.
  • Carlos Gilberto Carlotti Junior Departamento de Cirurgia e Anatomia do Hospital das Clínicas (HC) da Universidade de São Paulo (USP). Ribeirão Preto (SP), Brasil.
  • Harley Francisco de Oliveira Divisão de Radioterapia do Hospital das Clínicas (HC) da Universidade de São Paulo (USP). Ribeirão Preto (SP), Brasil.
  • Fernanda Maris Peria Divisão de Oncologia Clínica do Hospital das Clínicas (HC) da Universidade de São Paulo (USP). Ribeirão Preto (SP), Brasil. https://orcid.org/0000-0001-5133-165X

DOI:

https://doi.org/10.32635/2176-9745.RBC.2016v62n1.414

Keywords:

Glioblastoma, Radiotherapy/adverse effects, Sarcoma, Masculino, Case Reports

Abstract

Introduction: Glioblastoma multiforme and neoplasia is the deadliest cancer of the central nervous system, with survival rates averaging around 13 months and it shows the worst prognosis among all gliomas. The therapeutic approach of glioblastoma is based on a full neurosurgical resection of the tumor volume followed by radiotherapy and chemotherapy. Radiotherapy reduces the risk of recurrence by direct and indirect deoxyribonucleic acid damage of the tumor. The long-term effects of radiotherapy include tissue necrosis, vascular injury and neoplasia induced by radiation. The majority of secondary intracranial tumors and most commonly reported include meningiomas, gliomas and sarcomas. The latency period between the cranial radiotherapy and the onset of radiation-induced injuries in the literature varies between six months to 47 years, with an average of 18.7 years. Case report: This report describes the onset of spindle cell sarcoma of highly radiation-induced after ten months in a patient who received treatment of Glioblastoma at the General Hospital of the University of Sao Paulo Medical School, Ribeirao Preto. Conclusion: The rarity of this association is probably due to poor survival of patients with Glioblastoma, thus limiting the time for development of secondary malignancies.

Downloads

Download data is not yet available.

Published

2016-03-31

How to Cite

1.
Domingos Lisita Rosa V, Souza dos Anjos C, Barile Marchi Candido P, Soares Dias Junior A, Airton Sordi dos Santos E, Cavalcante Godoy AC, P. Saggioro F, Carlotti Junior CG, Francisco de Oliveira H, Maris Peria F. Radiation Induced Sarcoma after Treatment of Glioblastoma: Case Report. Rev. Bras. Cancerol. [Internet]. 2016 Mar. 31 [cited 2024 Jul. 22];62(1):51-7. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/414

Issue

Section

CASE REPORT